USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement
24-Dec-2015
North America
Market Research
9AB9-00-46-00-00
LS00160-NA-MR_17130
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.
Summary
Market Outlook
Current Regulatory Status of NGS Instruments
Evolution of NGS Testing
NGS for Clinical versus Research Applications
Market Outlook on NGS Clinical Markets—Global
NGS Clinical Landscape—China
NGS Clinical Landscape—United States
Untapped Market for Clinical Applications of NGS—Global
Opportunity Assessment for Clinical NGS
Use of NGS Technology—Global
NGS-based Companion Diagnostics a Near-term Possibility
Points to Consider
Current Protocols for Reimbursement
Success Stories of 3 Companies—What Drives Reimbursement?
Genomic Health
Veracyte
Veracyte (Illumina)
Summary of Reimbursement Coverage Best Practices
Top Bottlenecks
Lessons from Early Adopters
Survey on Clinical NGS
Survey on Clinical NGS (continued)
Key Conclusions and Future Outlook
Analysis from the Genetic Test Repository (GTR)
Test Purpose
Test Method—NGS, Microarray, Sanger, and CGH Based
Tests Offered By Location
Tests Offered By Location (continued)
Selected NGS-based Tests with Clinical Significance
Selected NGS-based Tests with Clinical Significance (continued)
Selected NGS-based Tests with Clinical Significance (continued)
NGS Clinical Test Provider Profiles
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
List for DTC Genetic Testing
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
FDA’s Warning Letters to Manufacturers
List of Approved Companion Diagnostic Kits
List of Approved Companion Diagnostic Kits (continued)
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Next Generation Sequencing (NGS) Market Research research
13 Sep 2016 | North America | Market Research
US Next-generation Sequencing Services Market
The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e...
22 Sep 2014 | North America | Customer Research
Global Next-generation Sequencing Trends
The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteri...
20 Jun 2014 | Global | Market Research
Global Next-generation Sequencing Market
The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencin...
11 Jun 2014 | Global | Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with...
08 Oct 2013 | Global | Market Research
Global Next Generation Sequencing Informatics Market
More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the impor...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | 9AB9-00-46-00-00 |
| Is Prebook | No |
Global Clinical Next-generation Sequencing Market
$1,500.00
Special Price $1,125.00 save 25 %